Is RLMD or RLYB more undervalued in 2026?

CirclFi compares Relmada Therapeutics, Inc. (RLMD) and Rallybio Corporation (RLYB) using 13 institutional-grade valuation models. RLMD has a Quality of Company score of 4.4/10 while RLYB scores 5.4/10.

Which is a better buy — RLMD or RLYB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RLMD and RLYB valuations compare?

RLMD at $7.25 and RLYB at $14.52 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RLMD vs RLYB Valuation Comparison 2026 — Intrinsic Value Analysis

RLMD

Biotechnology

Relmada Therapeutics, Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$7.25

Last close

Models

7/13

Active

RLYB

Biotechnology

Rallybio Corporation

Quality

5.4

out of 10

Value Trap

SAFE

Price

$14.52

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	RLMD Fair Value	RLMD Upside	RLYB Fair Value	RLYB Upside
Bayesian DCF	Intrinsic	$1.99	-72.6%	$8.15	-43.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.53	-78.9%	$17.56	+20.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RLMD vs RLYB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RLMD vs RLYB — Which Stock Is More Undervalued?

RLYB scores higher with a 5.4/10 quality rating vs RLMD's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Relmada Therapeutics, Inc. (RLMD) and Rallybio Corporation (RLYB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RLMD currently trades at $7.25 with a QOC of 4.4/10, while RLYB trades at $14.52 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).